13F HOLDINGS REPORT
Trails Edge Capital Partners, LP
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0002077247-26-000002
Total Value
$404.7M
Positions
23
Other Managers
0
Confidential Omitted
No
Holdings (23)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACADIA PHARMACEUTICALS INC | ACAD | 1,419,406 | $37.9M | 9.37% |
| 2 | MIND MEDICINE MINDMED INC | 60255C885 | 2,568,110 | $34.4M | 8.50% |
| 3 | VAXCYTE INC | PCVX | 737,470 | $34.0M | 8.41% |
| 4 | NURIX THERAPEUTICS INC | NRIX | 1,743,220 | $33.1M | 8.17% |
| 5 | LB PHARMACEUTICALS INC | LBRX | 1,395,608 | $31.1M | 7.68% |
| 6 | XENON PHARMACEUTICALS INC | XENE | 597,092 | $26.8M | 6.61% |
| 7 | IMMUNOCORE HLDGS PLC | IMCR | 682,597 | $23.7M | 5.85% |
| 8 | ARCUS BIOSCIENCES INC | RCUS | 916,313 | $21.8M | 5.40% |
| 9 | TYRA BIOSCIENCES INC | TYRA | 700,000 | $18.4M | 4.55% |
| 10 | NEUROGENE INC | NGNE | 785,000 | $16.2M | 4.00% |
| 11 | AMICUS THERAPEUTICS INC | FOLD | 1,043,313 | $14.9M | 3.67% |
| 12 | APOGEE THERAPEUTICS INC | APGE | 192,000 | $14.5M | 3.58% |
| 13 | INHIBIKASE THERAPEUTICS INC | IKT | 6,178,124 | $12.7M | 3.13% |
| 14 | INVENTIVA SA | IVEVF | 2,657,997 | $12.4M | 3.05% |
| 15 | CAMP4 THERAPEUTICS CORP | CAMP | 1,983,986 | $12.2M | 3.00% |
| 16 | TERNS PHARMACEUTICALS INC | TERN | 300,000 | $12.1M | 2.99% |
| 17 | X4 PHARMACEUTICALS INC | XFOR | 2,571,478 | $10.3M | 2.54% |
| 18 | MBX BIOSCIENCES INC | MBX | 315,158 | $9.9M | 2.46% |
| 19 | VTV THERAPEUTICS INC | VTVT | 231,000 | $9.2M | 2.28% |
| 20 | COMPASS THERAPEUTICS INC | CMPX | 1,415,273 | $7.6M | 1.88% |
| 21 | IMMUNOVANT INC | IMVT | 240,165 | $6.1M | 1.51% |
| 22 | ENLIVEN THERAPEUTICS INC | ELVN | 199,306 | $3.1M | 0.76% |
| 23 | MIRUM PHARMACEUTICALS INC | MIRM | 31,862 | $2.5M | 0.62% |